FDA experts: Ease restrictions on GSK's Avandia

06/6/2013 | CNN · Reuters

Twenty of 26 members of an FDA advisory panel voted Thursday to relax or end restrictions on GlaxoSmithKline's diabetes drug Avandia. Several panel members expressed support for additional research into the cardiovascular risks associated with the drug, but some experts said it was unlikely funding would be available.

View Full Article in:

CNN · Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations